Jun 08, 2021 / 03:20PM GMT
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Hello, and welcome, everybody. My name is Chris Shibutani. I'm a member of the Goldman Sachs biotech equity research group. Welcome to our 42nd Annual Healthcare Conference, virtual this year, hopefully, live next year. We're very pleased to have Seres Therapeutics join us for the presentation. As you can see from all the panes that we have just about everybody from the C-suite. Nobody is doing any work other than with us for the next hour. So we'll try to make sure we get the most of everybody's time.
Joining us, and I have my little cheat sheet here is Eric Shaff, who's the President and CEO; David Arkowitz, who is the recently appointed Chief Financial Officer. David, welcome to this craziness. Lisa von Moltke, who is the Chief Medical Officer; Terri Young, Chief Commercial and Strategic Officer; and Matt Henn, who is the Chief Scientific Officer. Often in the wings, probably biting his nails, worried is Carlo Tanzi from Investor Relations. So we'll give Carlo a quick shout out even though he's not on camera. So
Seres Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers